A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjects
This study has been completed.
First Posted: November 25, 2010
Last Update Posted: September 9, 2014
Information provided by (Responsible Party):